Diabetes mellitus Type 2 and the accumulation of advanced glycation end products in female vs. male patients

被引：0
|
作者：
Goettke, Sophie [1 ,2 ]
Wagner, Michael [1 ]
Maftei, Daniela [1 ]
Khadim, H. [1 ]
Palmeshofer, Anton [1 ]
Posset, Andreas [1 ]
Handl, Martina [1 ]
Wuerfel, Reinhard [1 ]
Al-Taie, Nawras [3 ]
Stingl, Harald [1 ,2 ]
机构：
[1] Hosp Melk, Dept Internal Med, Melk, Austria
[2] Karl Landsteiner Univ Hlth Studies, Krems, Austria
[3] Hosp Modling, Dept Internal Med, Modling, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2021年 / 133卷 / SUPPL 6期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
52
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [41] Genetic Variants of the Receptor for Advanced Glycation End-products in Susceptibility to Type 2 Diabetes Mellitus in Primary Hypertensive Patients
    Yang, Hualing
    Nie, Yangyang
    Chen, Zhenyi
    Ye, Linyang
    Wang, Qingxiang
    Wang, Zhanxiang
    SCIENTIFIC REPORTS, 2017, 7
  • [42] Genetic Variants of the Receptor for Advanced Glycation End-products in Susceptibility to Type 2 Diabetes Mellitus in Primary Hypertensive Patients
    Hualing Yang
    Yangyang Nie
    Zhenyi Chen
    Linyang Ye
    Qingxiang Wang
    Zhanxiang Wang
    Scientific Reports, 7
  • [43] Assessing the accumulation of advanced glycation end products among patients with type 2 diabetes and the correlation to other cardiovascular risk factors
    Al-Taie, Nawras
    Maftei, Delia
    Khadim, Hussein
    Jabr, Jamal
    Palmeshofer, Anton
    Posset, Andreas
    Handl, Martina
    Dirtl, Gabi
    Wuerfel, Reinhard
    Stingl, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S360 - S361
  • [44] Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus
    Luevano-Contreras, Claudia
    Garay-Sevilla, Ma. Eugenia
    Wrobel, Kazimierz
    Malacara, Juan M.
    Wrobel, Katarzyna
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2013, 52 (01) : 22 - 26
  • [45] Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes
    Nakamura, N
    Yamazaki, K
    Satoh, A
    Urakaze, M
    Kobayashi, M
    Yamabe, H
    Osawa, H
    Shirato, K
    Sugawara, T
    Nakamura, M
    Tamura, M
    Okumura, K
    IN VIVO, 2003, 17 (02): : 177 - 180
  • [46] Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients
    Takeda, Munehiro
    Ojima, Miki
    Yoshioka, Hideo
    Inaba, Hiroaki
    Kogo, Mikihiko
    Shizukuishi, Satoshi
    Nomura, Makoto
    Amano, Atsuo
    JOURNAL OF PERIODONTOLOGY, 2006, 77 (01) : 15 - 20
  • [47] Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease
    Cimen, B.
    Gelisgen, R.
    Andican, G.
    Yumuk, V.
    Bolayirli, M.
    Hacibekiroglu, M.
    Burcak, G.
    FEBS JOURNAL, 2006, 273 : 209 - 209
  • [48] Advanced Glycation End Products in Pregnancies Complicated with Diabetes Mellitus or Preeclampsia
    Harsem, Nina K.
    Braekke, Kristin
    Torjussen, Tale
    Hanssen, Kristian
    Staff, Anne Cathrine
    HYPERTENSION IN PREGNANCY, 2008, 27 (04) : 374 - 386
  • [49] Advanced glycation end products (AGEs) and sRAGE levels after benfotiamine treatment in diabetes mellitus type 2
    Luevano Contreras, Claudia
    Guzman-Rosiles, Ixchel
    Del Castillo, Dolores
    Gomez-Ojeda, Armando
    Eugenia Garay-Sevilla, Ma
    FASEB JOURNAL, 2017, 31
  • [50] Relationship between advanced glycation end products and gestational diabetes mellitus
    Li, Shuang
    Yang, Huixia
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (17): : 2783 - 2789
12345